Catalyst Wire Dossier Catalyst Wire Dossier

Trivalent subunit influenza vaccine (mammalian cell culture)

Influenza vaccine, inactivated, cell culture-derived · Novartis Vaccines
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Trivalent subunit influenza vaccine (mammalian cell culture), covering 2013-01-17 to 2013-01-17. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Immunogenicity of Trivalent Subunit Influenza Vaccine Produced in Mammalian Cell Culture Using the Strain Composition 2007/2008 [Phase 3]

See pricing